BioHealth News Archive
Commerce secretary, local experts (Including BHI’s Sarah Miller) project how recession would affect life sciences | Biotech | fredericknewspost.com
Is there a recession on the horizon? Some economists say yes — and predict it’s going to be bad — while others say the…
Read More
miRecule Enters into Strategic Collaboration with Sanofi to Accelerate Discovery and Development of a Best-in-Class Antibody-RNA Conjugate to Treat Facioscapulohumeral Muscular Dystrophy (FSHD) | Business Wire
Partnership combines miRecule’s unique RNA therapeutic discovery and conjugation platforms with Sanofi’s NANOBODY® technology to create a groundbreaking treatment for FSHD miRecule will receive…
Read More
Gaithersburg’s Adaptive Phage Therapeutics Awarded Additional $5 Million from U.S. Defense Health Agency to Support Diabetic Foot Osteomyelitis Clinical Trial
October 04, 2022 08:29 AM Eastern Daylight Time GAITHERSBURG, Md--(BUSINESS WIRE)--Adaptive Phage Therapeutics, Inc. (“APT”), a clinical-stage biotechnology company advancing the world’s largest therapeutic…
Read More
Johns Hopkins University partners with NIH, Howard University for accelerator – Washington Business Journal
Johns Hopkins University is teaming with two D.C.-area institutions, Howard University and the National Institutes of Health, to create a new accelerator to help…
Read More
How Do We Bolster the BioHealth Capital Region Workforce? · BioBuzz
The BioHealth Capital Region has made a name for itself in the last few years, currently holding tight to its #4 ranking on the…
Read More
8th Annual BioHealth Capital Region Forum Recap
Did you miss the 8th Annual BioHealth Capital Region Forum? Below we are sharing many of the panels, fireside chats, and keynotes from this…
Read More
Registration is Now Open for Quantum World Congress
Quantum World Congress is where global trailblazers, game-changers, innovators, and visionaries come together to accelerate a quantum-ready future Quantum World Congress is the first-of-its-kind…
Read More
Do you have groundbreaking technology that can diagnosis or treat disorders of nervous system?
We are pleased to share an exciting new funding opportunity from the NIH Blueprint Innovation Hubs that you or your colleagues may be interested…
Read More
SISU Global Names One of MedTech’s 100 Largest Players
#KeiretsuBacked Sisu Global named in the list of the 100 Most Influential Medtech Companies! They were awarded in the latest issue of Medical Design…
Read More
NIIMBL Releases the First Industry-wide Biomanufacturing Readiness Level Framework for Biologics
NEWARK, Del., Sept. 29, 2022 /PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announces a Biomanufacturing Readiness Levels (BRLs) framework to…
Read More
SOLVE FSHD Invests US $1 Million in miRecule to Accelerate Development of Best-in-Class Antibody-RNA Conjugate to Treat Facioscapulohumeral Muscular Dystrophy
GAITHERSBURG, Maryland and VANCOUVER, British Columbia – September 29, 2022 – miRecule, Inc., an innovator of next-generation RNA therapeutics, and SOLVE FSHD, a venture-philanthropy organization catalyzing…
Read More
Administrator Guzman Applauds Passage of Small Business Innovation Research (SBIR) Program Reauthorization, Committing to Scientific and Technology Innovation
WASHINGTON – Administrator Isabella Casillas Guzman, head of the U.S. Small Business Administration and voice for America's 33 million small businesses in President Biden's…
Read More
Commerce secretary, local experts project how recession would affect life sciences
Some economists say yes — and predict it's going to be bad — while others say the United States will avoid one altogether. Still…
Read More
Additional Information on New NIH MedTech Program: Incubator hubs will provide subawards to technology innovation teams and aim to accelerate medical devices to treat, diagnose nervous system disorders – The LaunchPort
Newswise — The National Institutes of Health, through its Blueprint MedTech program, has established two incubator hubs and launched a funding solicitation in support of commercially…
Read More
MaxCyte Signs Strategic Platform License with Vertex Pharmaceuticals to Advance CRISPR/Cas9-based Gene-editing Program
Vertex Pharmaceuticals will continue to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support gene-edited cell therapy exa-cel, formerly known as CTX001™ for hemoglobinopathies ROCKVILLE,…
Read More